Eben Tessari - Net Worth and Insider Trading
Eben Tessari Net Worth
The estimated net worth of Eben Tessari is at least $2 Million dollars as of 2024-11-05. Eben Tessari is the CHIEF OPERATING OFFICER of Kiniksa Pharmaceuticals International PLC and owns about 109,975 shares of Kiniksa Pharmaceuticals International PLC (KNSA) stock worth over $2 Million. Details can be seen in Eben Tessari's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eben Tessari has not made any transactions after 2024-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eben Tessari
Eben Tessari Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eben Tessari owns 1 companies in total, including Kiniksa Pharmaceuticals International PLC (KNSA) .
Click here to see the complete history of Eben Tessari’s form 4 insider trades.
Insider Ownership Summary of Eben Tessari
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International PLC | 2024-10-15 | Chief Business Officer |
Eben Tessari Latest Holdings Summary
Eben Tessari currently owns a total of 1 stock. Eben Tessari owns 109,975 shares of Kiniksa Pharmaceuticals International PLC (KNSA) as of October 15, 2024, with a value of $2 Million.
Latest Holdings of Eben Tessari
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International PLC | 2024-10-15 | 109,975 | 21.90 | 2,408,453 |
Holding Weightings of Eben Tessari
Eben Tessari Form 4 Trading Tracker
According to the SEC Form 4 filings, Eben Tessari has made a total of 3 transactions in Kiniksa Pharmaceuticals International PLC (KNSA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Kiniksa Pharmaceuticals International PLC is the sale of 17,000 shares on October 15, 2024, which brought Eben Tessari around $456,790.
Insider Trading History of Eben Tessari
- 1
Eben Tessari Trading Performance
Eben Tessari Ownership Network
Ownership Network List of Eben Tessari
Ownership Network Relation of Eben Tessari
Eben Tessari Owned Company Details
What does Kiniksa Pharmaceuticals International PLC do?
Who are the key executives at Kiniksa Pharmaceuticals International PLC?
Eben Tessari is the Chief Business Officer of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include Group VP & Rilonacept GM Ross Moat , Chief Medical Officer John Paolini , and Interim CFO Mark Ragosa .
Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary
Over the past 18 months, Eben Tessari made 3 insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA) with a net sale of 52,000. Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 150,848 shares made by John Paolini , a net sale of 219,460 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .
In summary, during the past 3 months, insiders sold 181,198 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 181,198 shares. During the past 18 months, 539,163 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 539,163 shares.
Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals International PLC Insider Transactions
Eben Tessari Mailing Address
Above is the net worth, insider trading, and ownership report for Eben Tessari. You might contact Eben Tessari via mailing address: C/o Kiniksa Pharmaceuticals Ltd., Clarendon House, 2 Church Street, Hamilton D0 Hm11.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
